IL22 and inflammatory bowel disease: With respect to IBD, gut microbiota-mediated metabolism of tryptophan into indole derivatives provide the ligands for AhR, which subsequently drives IL-22-dependent regeneration of mucosal barrier integrity and reduces pro-inflammatory potential (13).